169 related articles for article (PubMed ID: 30468460)
1. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2.
Zou MF; Ling J; Wu QY; Zhang CX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7183-7188. PubMed ID: 30468460
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
Yang Q; Yu Y; Sun Z; Pan Y
Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
Qu C; Dai C; Guo Y; Qin R; Liu J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion.
Wang Y; Zhou J; Wang Z; Wang P; Li S
Biochem Biophys Res Commun; 2017 Nov; 493(1):429-436. PubMed ID: 28882595
[TBL] [Abstract][Full Text] [Related]
5. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p/RUNX2 axis.
Yu X; Zhao J; He Y
J BUON; 2018; 23(1):48-54. PubMed ID: 29552759
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA plasmacytoma variant translocation 1 inhibits cell proliferation while promotes cell apoptosis via regulating miR-486-mediated CDK4 and BCAS2 in multiple myeloma.
Zhang M; Zhao X; Cai X; Wang P; Yu M; Wei Z
Ir J Med Sci; 2020 Aug; 189(3):825-834. PubMed ID: 31900844
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA DSCAM-AS1 indicates a poor prognosis and modulates cell proliferation, migration and invasion in ovarian cancer via upregulating SOX4.
Li Y; Hao J; Jiang YM; Liu Y; Zhang SH
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4143-4148. PubMed ID: 31173284
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA PVT1/miR-150/ HIG2 Axis Regulates the Proliferation, Invasion and the Balance of Iron Metabolism of Hepatocellular Carcinoma.
Xu Y; Luo X; He W; Chen G; Li Y; Li W; Wang X; Lai Y; Ye Y
Cell Physiol Biochem; 2018; 49(4):1403-1419. PubMed ID: 30205391
[TBL] [Abstract][Full Text] [Related]
10. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.
Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855
[TBL] [Abstract][Full Text] [Related]
11. Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway.
Chen Y; Li F; Li D; Liu W; Zhang L
Clin Immunol; 2021 Jun; 227():108728. PubMed ID: 33878452
[TBL] [Abstract][Full Text] [Related]
12. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1.
Tian Z; Cao S; Li C; Xu M; Wei H; Yang H; Sun Q; Ren Q; Zhang L
J Cell Physiol; 2019 Apr; 234(4):4799-4811. PubMed ID: 30317572
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
[TBL] [Abstract][Full Text] [Related]
16. Up-regulated lnc-lung cancer associated transcript 1 enhances cell migration and invasion in breast cancer progression.
Li YL; Wang XM; Qiao GD; Zhang S; Wang J; Cong YZ; Zhu SG
Biochem Biophys Res Commun; 2020 Jan; 521(2):271-278. PubMed ID: 31635802
[TBL] [Abstract][Full Text] [Related]
17. Tissue-based long non-coding RNAs "PVT1, TUG1 and MEG3" signature predicts Cisplatin resistance in ovarian Cancer.
El-Khazragy N; Mohammed HF; Yassin M; Elghoneimy KK; Bayoumy W; Hewety A; El Magdoub HM; Elayat W; Zaki W; Safwat G; Mosa M; Zedan K; Salem S; Bannunah AM; Mansy A
Genomics; 2020 Nov; 112(6):4640-4646. PubMed ID: 32781203
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
Hong L; Chen W; Wu D; Wang Y
Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA DANCR upregulates IGF2 expression and promotes ovarian cancer progression.
Gao YQ; Cheng HY; Liu KF
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3621-3626. PubMed ID: 31114986
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG14 enhances migration and invasion of ovarian cancer by upregulating DGCR8.
Zhao JL; Wang CL; Liu YL; Zhang GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10226-10233. PubMed ID: 31841176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
